Results 41 to 50 of about 1,046,073 (109)

Minimal Residual Disease as an Early Endpoint for Accelerated Drug Approval in Myeloma: A Roadmap. [PDF]

Blood Cancer Discov
Landgren O, Devlin SM.
europepmc   +1 more source

Critical insights into the evolving drug-approval process in China. [PDF]

Cancer
Nikanjam M, Kurzrock R.
europepmc   +1 more source

Getting the Right Evidence After Drug Approval. [PDF]

Front Pharmacol, 2020
Vreman RA, Leufkens HGM, Kesselheim AS.
europepmc   +1 more source

The evolutionary safety of mutagenic drugs should be assessed before drug approval. [PDF]

PLoS Biol
Lobinska G, Tretyachenko V, Dahan O, Nowak MA, Pilpel Y.   +4 more
europepmc   +1 more source

Targeted Therapies, Novel Antibodies, and Immunotherapies in Advanced Non-Small Cell Lung Cancer: Clinical Evidence and Drug Approval Patterns. [PDF]

Clin Cancer Res
Koban MU, Hartmann M, Amexis G, Franco P, Huggins L, Shah I, Karachaliou N.   +6 more
europepmc   +1 more source

Making Drug Approval Decisions in the Face of Uncertainty: Cumulative Evidence versus Value of Information. [PDF]

Med Decis Making
Dijk SW, Krijkamp E, Kunst N, Labrecque JA, Gross CP, Pandit A, Lu CP, Visser LE, Wong JB, Hunink MGM.   +9 more
europepmc   +1 more source

Disease modification in osteoarthritis; pathways to drug approval. [PDF]

Osteoarthr Cartil Open, 2020
Katz JN, Neogi T, Callahan LF, Block JA, Conaghan PG, Simon LS, Kraus VB, Hochberg MC.   +7 more
europepmc   +1 more source

How improvements in US FDA regulatory process and procedures led to the drug approval for first ever treatment of a common liver disease. [PDF]

Acta Pharmacol Sin
Harvey BE.
europepmc   +1 more source

From Drug Discovery to Drug Approval: A Comprehensive Review of the Pharmacogenomics Status Quo with a Special Focus on Egypt. [PDF]

Pharmaceuticals (Basel)
Elgarhy FM, Borham A, Alziny N, AbdElaal KR, Shuaib M, Musaibah AS, Hussein MA, Abdelnaser A.   +7 more
europepmc   +1 more source

Clinical Trial Design and Drug Approval in Oncology: A Primer for the Advanced Practitioner in Oncology. [PDF]

J Adv Pract Oncol, 2020
Kurtin SE, Taher R.
europepmc   +1 more source